• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
MGZ
Click for more information
0.00% 2.0¢

MEDIGARD LIMITED - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
Filters [Clear]
  • Price Sensitive: Yes
MGZ Suspension from Official QuotationPRICE SENSITIVE08/03/19
MGZ Half Yearly Report and AccountsPRICE SENSITIVE27/02/19
MGZ Appendix 4C - quarterlyPRICE SENSITIVE31/01/19
MGZ Medigard KT009 project and funding strategyPRICE SENSITIVE11/12/18
MGZ Explaining Medigard's New KT009 ProgramPRICE SENSITIVE14/11/18
MGZ License Agreement with Kunovus Pty LtdPRICE SENSITIVE08/11/18
MGZ Appendix 4C - quarterlyPRICE SENSITIVE31/10/18
MGZ Technology License and Clinial Development Program AgreementPRICE SENSITIVE30/10/18
MGZ Letter to ShareholdersPRICE SENSITIVE04/10/18
MGZ Preliminary Final ReportPRICE SENSITIVE30/08/18
MGZ Appendix 4C - quarterlyPRICE SENSITIVE24/07/18 download Created with Sketch. 314.31KB
MGZ Announcement re Technology and Commercialisation AgreementPRICE SENSITIVE29/05/18 download Created with Sketch. 359.07KB
MGZ Appendix 4C - quarterlyPRICE SENSITIVE27/04/18
MGZ Half Yearly Report and AccountsPRICE SENSITIVE28/02/18
MGZ Appendix 4C - quarterlyPRICE SENSITIVE30/01/18
MGZ Share Purchase Plan Offer DocumentsPRICE SENSITIVE08/12/17
MGZ Share Purchase PlanPRICE SENSITIVE07/12/17
MGZ Private Placement CommitmentsPRICE SENSITIVE31/10/17
MGZ Appendix 4C - quarterlyPRICE SENSITIVE31/10/17
MGZ Preliminary Final ReportPRICE SENSITIVE31/08/17
MGZ Appendix 4C - quarterlyPRICE SENSITIVE31/07/17
MGZ Appendix 4C - quarterlyPRICE SENSITIVE24/04/17
MGZ Half Year AccountsPRICE SENSITIVE28/02/17
MGZ Appendix 4C - quarterlyPRICE SENSITIVE30/01/17
MGZ Appendix 4C - quarterly-MGZ.AX PRICE SENSITIVE24/10/16
MGZ Preliminary Final Report-MGZ.AX PRICE SENSITIVE28/08/16
MGZ Preliminary Final Report-MGZ.AX PRICE SENSITIVE25/08/16
MGZ Appendix 4C - quarterly-MGZ.AX PRICE SENSITIVE29/07/16
MGZ Appendix 4C - quarterly-MGZ.AX PRICE SENSITIVE27/04/16
MGZ Half Year Report and AccountsPRICE SENSITIVE26/02/16
MGZ Appendix 4C - quarterlyPRICE SENSITIVE29/01/16
MGZ Response to ASX Appendix 4C QueryPRICE SENSITIVE05/11/15
MGZ Appendix 4C - quarterlyPRICE SENSITIVE27/10/15
MGZ Preliminary Final ReportPRICE SENSITIVE31/08/15
MGZ Shareholder UpdatePRICE SENSITIVE21/07/15
MGZ Appendix 4C - quarterlyPRICE SENSITIVE21/07/15
MGZ Shareholder UpdatePRICE SENSITIVE14/05/15
MGZ Appendix 4C - quarterlyPRICE SENSITIVE30/04/15
MGZ Half Year AccountsPRICE SENSITIVE26/02/15
MGZ Response to ASX Price QueryPRICE SENSITIVE06/02/15
MGZ Appendix 4C - quarterlyPRICE SENSITIVE21/01/15
MGZ Appendix 4C - quarterlyPRICE SENSITIVE24/10/14
MGZ Preliminary Final ReportPRICE SENSITIVE29/08/14
MGZ Convertible Note DeedPRICE SENSITIVE31/07/14
MGZ Appendix 4C - quarterlyPRICE SENSITIVE30/07/14
MGZAppendix 4C - quarterlyPRICE SENSITIVE30/04/14
MGZHalf Yearly Report and AccountsPRICE SENSITIVE28/02/14
MGZAppendix 4C - quarterlyPRICE SENSITIVE30/01/14
MGZAppendix 4C - quarterlyPRICE SENSITIVE21/10/13
MGZPreliminary Final ReportPRICE SENSITIVE28/08/13
MGZAppendix 4C - quarterlyPRICE SENSITIVE04/07/13
MGZAppendix 4C - quarterlyPRICE SENSITIVE18/04/13
MGZHalf Yearly Report and AccountsPRICE SENSITIVE28/02/13
MGZAppendix 4C - quarterlyPRICE SENSITIVE10/01/13
MGZAppendix 4C - quarterlyPRICE SENSITIVE29/10/12
MGZMedigard announces Heads of AgreementPRICE SENSITIVE24/10/12
MGZPreliminary Final ReportPRICE SENSITIVE28/08/12
MGZAppendix 4C - quarterlyPRICE SENSITIVE30/07/12
MGZAppendix 4C - quarterlyPRICE SENSITIVE30/04/12
MGZHalf Yearly Report and AccountsPRICE SENSITIVE29/02/12
MGZAppendix 4C - quarterlyPRICE SENSITIVE30/01/12
MGZAppendix 4C - quarterlyPRICE SENSITIVE25/10/11
MGZPreliminary Final ReportPRICE SENSITIVE31/08/11
MGZAppendix 4C - quarterlyPRICE SENSITIVE29/07/11
MGZAppendix 4C - 31 March 2011PRICE SENSITIVE29/04/11
MGZNotice of Resignation CEO and Company SecretaryPRICE SENSITIVE24/02/11
MGZHalf Yearly Report and AccountsPRICE SENSITIVE24/02/11
MGZGrant of Japanese Patent (BCD) and IPRP (1mL Syringe)PRICE SENSITIVE01/02/11
MGZAppendix 4C - quarterlyPRICE SENSITIVE28/01/11
MGZAppendix 4C - quarterlyPRICE SENSITIVE28/10/10
MGZGrant of Patent in South AfricaPRICE SENSITIVE21/09/10
MGZPreliminary Final ReportPRICE SENSITIVE31/08/10
MGZMarket AnnouncementPRICE SENSITIVE05/08/10
MGZAppendix 4C - quarterlyPRICE SENSITIVE29/07/10
MGZProspectusPRICE SENSITIVE27/07/10
MGZRenounceable IssuePRICE SENSITIVE27/07/10
MGZSigning of US Manufacturing and Distribution AgreementsPRICE SENSITIVE26/05/10
MGZTrading HaltPRICE SENSITIVE25/05/10
MGZAppendix 4C - quarterlyPRICE SENSITIVE16/04/10
MGZClinical Trial Results USA - Medigard SyringePRICE SENSITIVE06/04/10
MGZMarketing and Product Evaluation USAPRICE SENSITIVE24/03/10
MGZHalf Yearly Report and AccountsPRICE SENSITIVE26/02/10
MGZAppendix 4C - quarterlyPRICE SENSITIVE25/01/10
MGZMedigard Signs US ManufacturerPRICE SENSITIVE11/12/09
MGZMarketing - Product Evaluation USAPRICE SENSITIVE12/11/09
MGZAppendix 4C - quarterlyPRICE SENSITIVE26/10/09
MGZPreliminary Final ReportPRICE SENSITIVE31/08/09
MGZAppendix 4C - quarterlyPRICE SENSITIVE30/07/09
MGZLetter to ShareholdersPRICE SENSITIVE07/07/09
MGZGrant of US PatentPRICE SENSITIVE10/06/09
MGZAppendix 4C - quarterlyPRICE SENSITIVE30/04/09
MGZBonus IssuePRICE SENSITIVE02/04/09
MGZHalf Yearly Report and AccountsPRICE SENSITIVE27/02/09
MGZShare Purchase PlanPRICE SENSITIVE11/02/09
MGZAppendix 4C - quarterlyPRICE SENSITIVE29/01/09
MGZFDA Approval for Blood Collection DevicePRICE SENSITIVE19/01/09
MGZ Suspension from Official Quotation
08/03/19PRICE SENSITIVE
MGZ Half Yearly Report and Accounts
27/02/19PRICE SENSITIVE
MGZ Appendix 4C - quarterly
31/01/19PRICE SENSITIVE
MGZ Medigard KT009 project and funding strategy
11/12/18PRICE SENSITIVE
MGZ Explaining Medigard's New KT009 Program
14/11/18PRICE SENSITIVE
MGZ License Agreement with Kunovus Pty Ltd
08/11/18PRICE SENSITIVE
MGZ Appendix 4C - quarterly
31/10/18PRICE SENSITIVE
MGZ Technology License and Clinial Development Program Agreement
30/10/18PRICE SENSITIVE
MGZ Letter to Shareholders
04/10/18PRICE SENSITIVE
MGZ Preliminary Final Report
30/08/18PRICE SENSITIVE
MGZ Appendix 4C - quarterly
24/07/18PRICE SENSITIVE download Created with Sketch. 314.31KB
MGZ Announcement re Technology and Commercialisation Agreement
29/05/18PRICE SENSITIVE download Created with Sketch. 359.07KB
MGZ Appendix 4C - quarterly
27/04/18PRICE SENSITIVE
MGZ Half Yearly Report and Accounts
28/02/18PRICE SENSITIVE
MGZ Appendix 4C - quarterly
30/01/18PRICE SENSITIVE
MGZ Share Purchase Plan Offer Documents
08/12/17PRICE SENSITIVE
MGZ Share Purchase Plan
07/12/17PRICE SENSITIVE
MGZ Private Placement Commitments
31/10/17PRICE SENSITIVE
MGZ Appendix 4C - quarterly
31/10/17PRICE SENSITIVE
MGZ Preliminary Final Report
31/08/17PRICE SENSITIVE
MGZ Appendix 4C - quarterly
31/07/17PRICE SENSITIVE
MGZ Appendix 4C - quarterly
24/04/17PRICE SENSITIVE
MGZ Half Year Accounts
28/02/17PRICE SENSITIVE
MGZ Appendix 4C - quarterly
30/01/17PRICE SENSITIVE
MGZ Appendix 4C - quarterly-MGZ.AX
24/10/16PRICE SENSITIVE
MGZ Preliminary Final Report-MGZ.AX
28/08/16PRICE SENSITIVE
MGZ Preliminary Final Report-MGZ.AX
25/08/16PRICE SENSITIVE
MGZ Appendix 4C - quarterly-MGZ.AX
29/07/16PRICE SENSITIVE
MGZ Appendix 4C - quarterly-MGZ.AX
27/04/16PRICE SENSITIVE
MGZ Half Year Report and Accounts
26/02/16PRICE SENSITIVE
MGZ Appendix 4C - quarterly
29/01/16PRICE SENSITIVE
MGZ Response to ASX Appendix 4C Query
05/11/15PRICE SENSITIVE
MGZ Appendix 4C - quarterly
27/10/15PRICE SENSITIVE
MGZ Preliminary Final Report
31/08/15PRICE SENSITIVE
MGZ Shareholder Update
21/07/15PRICE SENSITIVE
MGZ Appendix 4C - quarterly
21/07/15PRICE SENSITIVE
MGZ Shareholder Update
14/05/15PRICE SENSITIVE
MGZ Appendix 4C - quarterly
30/04/15PRICE SENSITIVE
MGZ Half Year Accounts
26/02/15PRICE SENSITIVE
MGZ Response to ASX Price Query
06/02/15PRICE SENSITIVE
MGZ Appendix 4C - quarterly
21/01/15PRICE SENSITIVE
MGZ Appendix 4C - quarterly
24/10/14PRICE SENSITIVE
MGZ Preliminary Final Report
29/08/14PRICE SENSITIVE
MGZ Convertible Note Deed
31/07/14PRICE SENSITIVE
MGZ Appendix 4C - quarterly
30/07/14PRICE SENSITIVE
MGZAppendix 4C - quarterly
30/04/14PRICE SENSITIVE
MGZHalf Yearly Report and Accounts
28/02/14PRICE SENSITIVE
MGZAppendix 4C - quarterly
30/01/14PRICE SENSITIVE
MGZAppendix 4C - quarterly
21/10/13PRICE SENSITIVE
MGZPreliminary Final Report
28/08/13PRICE SENSITIVE
MGZAppendix 4C - quarterly
04/07/13PRICE SENSITIVE
MGZAppendix 4C - quarterly
18/04/13PRICE SENSITIVE
MGZHalf Yearly Report and Accounts
28/02/13PRICE SENSITIVE
MGZAppendix 4C - quarterly
10/01/13PRICE SENSITIVE
MGZAppendix 4C - quarterly
29/10/12PRICE SENSITIVE
MGZMedigard announces Heads of Agreement
24/10/12PRICE SENSITIVE
MGZPreliminary Final Report
28/08/12PRICE SENSITIVE
MGZAppendix 4C - quarterly
30/07/12PRICE SENSITIVE
MGZAppendix 4C - quarterly
30/04/12PRICE SENSITIVE
MGZHalf Yearly Report and Accounts
29/02/12PRICE SENSITIVE
MGZAppendix 4C - quarterly
30/01/12PRICE SENSITIVE
MGZAppendix 4C - quarterly
25/10/11PRICE SENSITIVE
MGZPreliminary Final Report
31/08/11PRICE SENSITIVE
MGZAppendix 4C - quarterly
29/07/11PRICE SENSITIVE
MGZAppendix 4C - 31 March 2011
29/04/11PRICE SENSITIVE
MGZNotice of Resignation CEO and Company Secretary
24/02/11PRICE SENSITIVE
MGZHalf Yearly Report and Accounts
24/02/11PRICE SENSITIVE
MGZGrant of Japanese Patent (BCD) and IPRP (1mL Syringe)
01/02/11PRICE SENSITIVE
MGZAppendix 4C - quarterly
28/01/11PRICE SENSITIVE
MGZAppendix 4C - quarterly
28/10/10PRICE SENSITIVE
MGZGrant of Patent in South Africa
21/09/10PRICE SENSITIVE
MGZPreliminary Final Report
31/08/10PRICE SENSITIVE
MGZMarket Announcement
05/08/10PRICE SENSITIVE
MGZAppendix 4C - quarterly
29/07/10PRICE SENSITIVE
MGZProspectus
27/07/10PRICE SENSITIVE
MGZRenounceable Issue
27/07/10PRICE SENSITIVE
MGZSigning of US Manufacturing and Distribution Agreements
26/05/10PRICE SENSITIVE
MGZTrading Halt
25/05/10PRICE SENSITIVE
MGZAppendix 4C - quarterly
16/04/10PRICE SENSITIVE
MGZClinical Trial Results USA - Medigard Syringe
06/04/10PRICE SENSITIVE
MGZMarketing and Product Evaluation USA
24/03/10PRICE SENSITIVE
MGZHalf Yearly Report and Accounts
26/02/10PRICE SENSITIVE
MGZAppendix 4C - quarterly
25/01/10PRICE SENSITIVE
MGZMedigard Signs US Manufacturer
11/12/09PRICE SENSITIVE
MGZMarketing - Product Evaluation USA
12/11/09PRICE SENSITIVE
MGZAppendix 4C - quarterly
26/10/09PRICE SENSITIVE
MGZPreliminary Final Report
31/08/09PRICE SENSITIVE
MGZAppendix 4C - quarterly
30/07/09PRICE SENSITIVE
MGZLetter to Shareholders
07/07/09PRICE SENSITIVE
MGZGrant of US Patent
10/06/09PRICE SENSITIVE
MGZAppendix 4C - quarterly
30/04/09PRICE SENSITIVE
MGZBonus Issue
02/04/09PRICE SENSITIVE
MGZHalf Yearly Report and Accounts
27/02/09PRICE SENSITIVE
MGZShare Purchase Plan
11/02/09PRICE SENSITIVE
MGZAppendix 4C - quarterly
29/01/09PRICE SENSITIVE
MGZFDA Approval for Blood Collection Device
19/01/09PRICE SENSITIVE
refresh Created with Sketch. REFRESH
 

Top Stories

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

Samples among the highest-ever-graded uranium soil samples recorded in mineral exploration history, and an imminent drill run.
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
Breaking news: New opportunities for investors & companies - HotCopper opens to capital raising! Companies can now raise capital through HotCopper! It’s a development allowing a highly cost-effective service to ASX-listed companies, while opening new investment opportunities to investors.
This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s. 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.